Presentation to PATH staff on 23-May-14.
Delivered in Seattle with a video link to Washington and audio link to San Francisco.
Download the presentation for the speech narrative that is contained in the notes to the slides.
2. What is ColaLife and who am I?
ColaLife is a charity registered in the UK
Charity number: 1142516
• No paid employees
• Five voluntary trustees
• Focus on saving children’s lives
• Independent
• Our only project is in Zambia
• Looking for global impact through
• Disruptive innovation
• Generating robust evidence
• Sharing findings and learning
• No commercial interest
2009 2010 2011 2012 20131985
4. Our starting point
Coca-Cola seems to get everywhere in
developing countries, yet life-saving
medicines don't. Why?
5. impac
t Mothers in underserved rural
communities increase use of ORS and
Zinc in home treatment of diarrhoea
purpose
Target communities in two under-served
rural districts have improved access to
ORS and Zinc
outputs
Profit-driven supply chains improve
availability of ADKs (anti-diarrhoea kits)
in targeted communities in two
underserved rural districts
Mothers/care-givers demonstrate
awareness of ADKs and the benefits of
the contents (ORS, Zinc and Soap)
access = ADK in the
hand of an aware
mother/care-giver
Availability = ADK in
stock in retail outlets
at community level
Generating robust evidence - the COTZ results framework
9. The Kit Yamoyo benefits
Kit Yamoyo
• Attractive
• ORS sachets are 200ml
10. The Kit Yamoyo benefits
Kit Yamoyo
• Attractive
• ORS sachets are 200ml
• Packaging is also:
11. The Kit Yamoyo benefits
Kit Yamoyo
• Attractive
• ORS sachets are 200ml
• Packaging is also:
• A measuring device for
the water
12. The Kit Yamoyo benefits
Kit Yamoyo
• Attractive
• ORS sachets are 200ml
• Packaging is also:
• A measuring device for
the water
• A mixing device
13. The Kit Yamoyo benefits
Kit Yamoyo
• Attractive
• ORS sachets are 200ml
• Packaging is also:
• A measuring device for
the water
• A mixing device
• A storage device (the
soap tray is a lid)
14. The Kit Yamoyo benefits
Kit Yamoyo
• Attractive
• ORS sachets are 200ml
• Packaging is also:
• A measuring device for
the water
• A mixing device
• A storage device (the
soap tray is a lid)
• A cup
15. The COTZ trial
Research Design & Methodology
Quasi-
experimental,
pre-test, post test
design baseline,
midline and endline
surveys
Target groups:
Care-givers of
under-5 children
and private
community
retailers
Four Districts – two
intervention
districts and two
matched
comparator
districts
Sample sizes:
625 HH per district
40 retailers per
district
Vouchers used to
launch the product
16. The COTZ trial
Distribution infrastructure and value chain
Pharmanova MSL Coca-Cola
wholesalers
• Standard Sales (2)
• Isusya’s
Approximately
85 retailers
across Katete
and Kalomo
Manufacture &
Assembly
Lusaka to
District
District to
Retailers
Mothers &
Care-givers
18. >26k
kits sold into the
two remote rural
trial areas in
12 months.
45%of children in trial
areas received
ORS/Zinc. Up
from a baseline
of <1%.
Comparator sites
stayed at <1%.
19. >26k
kits sold into the
two remote rural
trial areas in
12 months.
45%of children in trial
areas received
ORS/Zinc. Up
from a baseline
of <1%.
Comparator sites
stayed at <1%.
2.4km
The distance to
ORS/Zinc in the
trial areas was
reduced by two-
thirds from
7.3km to 2.4km.
20. >26k
kits sold into the
two remote rural
trial areas in
12 months.
45%of children in trial
areas received
ORS/Zinc. Up
from a baseline
of <1%.
Comparator sites
stayed at <1%.
2.4km
The distance to
ORS/Zinc in the
trial areas was
reduced by two-
thirds from
7.3km to 2.4km.
93%of Kit Yamoyo
users mixed ORS
correctly. Only
60% do when
given 1 litre
sachets.
21. 14The perception of
ORS as an
effective
treatment for
diarrhoea
increased by 14
percentage
points to 92%.
>26k
kits sold into the
two remote rural
trial areas in
12 months.
45%of children in trial
areas received
ORS/Zinc. Up
from a baseline
of <1%.
Comparator sites
stayed at <1%.
2.4km
The distance to
ORS/Zinc in the
trial areas was
reduced by two-
thirds from
7.3km to 2.4km.
93%of Kit Yamoyo
users mixed ORS
correctly. Only
60% do when
given 1 litre
sachets.
22. 14The perception of
ORS as an
effective
treatment for
diarrhoea
increased by 14
percentage
points to 92%.
>26k
kits sold into the
two remote rural
trial areas in
12 months.
45%of children in trial
areas received
ORS/Zinc. Up
from a baseline
of <1%.
Comparator sites
stayed at <1%.
2.4km
The distance to
ORS/Zinc in the
trial areas was
reduced by two-
thirds from
7.3km to 2.4km.
93%of Kit Yamoyo
users mixed ORS
correctly. Only
60% do when
given 1 litre
sachets.
4%Only 4% of kits
went into Coca-
Cola crates. It
was the space in
the market not
the space in the
crates that was
important.
25. 14The perception of
ORS as an
effective
treatment for
diarrhoea
increased by 14
percentage
points to 92%.
>26k
kits sold into the
two remote rural
trial areas in
12 months.
45%of children in trial
areas received
ORS/Zinc. Up
from a baseline
of <1%.
Comparator sites
stayed at <1%.
2.4km
The distance to
ORS/Zinc in the
trial areas was
reduced by two-
thirds from
7.3km to 2.4km.
93%of Kit Yamoyo
users mixed ORS
correctly. Only
60% do when
given 1 litre
sachets.
4%Only 4% of kits
went into Coca-
Cola crates. It
was the space in
the market not
the space in the
crates that was
important.
6International
awards for health
and design
innovation &
6 countries
interested in
replication.
26. Awards | The Kit Yamoyo has won many global awards
In Sep-13 it was featured at the UN General Assembly as a breakthrough innovation in Child Health.
In Mar-14 it was show-cased by PATH and PSI in their Best Buys for Global Health initiative.
27. 14The perception of
ORS as an
effective
treatment for
diarrhoea
increased by 14
percentage
points to 92%.
>26k
kits sold into the
two remote rural
trial areas in
12 months.
45%of children in trial
areas received
ORS/Zinc. Up
from a baseline
of <1%.
Comparator sites
stayed at <1%.
2.4km
The distance to
ORS/Zinc in the
trial areas was
reduced by two-
thirds from
7.3km to 2.4km.
93%of Kit Yamoyo
users mixed ORS
correctly. Only
60% do when
given 1 litre
sachets.
4%Only 4% of kits
went into Coca-
Cola crates. It
was the space in
the market not
the space in the
crates that was
important.
6International
awards for health
and design
innovation &
6 countries
interested in
replication.
...Request access
to our findings
colalife.org/
openaccess
28. 14The perception of
ORS as an
effective
treatment for
diarrhoea
increased by 14
percentage
points to 92%.
>26k
kits sold into the
two remote rural
trial areas in
12 months.
45%of children in trial
areas received
ORS/Zinc. Up
from a baseline
of <1%.
Comparator sites
stayed at <1%.
2.4km
The distance to
ORS/Zinc in the
trial areas was
reduced by two-
thirds from
7.3km to 2.4km.
93%of Kit Yamoyo
users mixed ORS
correctly. Only
60% do when
given 1 litre
sachets.
4%Only 4% of kits
went into Coca-
Cola crates. It
was the space in
the market not
the space in the
crates that was
important.
6International
awards for health
and design
innovation &
6 countries
interested in
replication.
...Request access
to our findings
colalife.org/
openaccess
29. ORS
Reduce number
of sachets to 4
NOTE: This will
also enhance
adherence
Zinc
Produce locally
Only include
blister pack
Soap
Produce locally
Leaflet Packaging
Remove
constraint of
fitting in Coca-
Cola crate
Produce locally
Produce re-fill
option
Oct 2013 | Incorporating the learning into the scale-up
31. ORS
Reduce number
of sachets to 4
NOTE: This may
also enhance
adherence to
the combined
therapy
Zinc
Produce locally
Only include
blister pack
Soap
Produce locally
Leaflet Packaging
Remove
constraint of
fitting in Coca-
Cola crate
Produce locally
Produce re-fill
option
4Oct 2013 | Incorporating the learning into the scale-up
34. ORS
Reduce number
of sachets to 4
This may also
enhance
adherence to
the combined
therapy
Zinc
Produce locally
Design the
blister pack to
enhance
adherence to
the 10-day
regime
Blister pack
needs no box
Soap
Produce locally
Leaflet Packaging
Remove
constraint of
fitting in Coca-
Cola crate
Produce locally
Produce re-fill
option
4Oct 2013 | Incorporating the learning into the scale-up
35. ORS
Reduce number
of sachets to 4
This may also
enhance
adherence to
the combined
therapy
Zinc
Produce locally
Design the
blister pack to
enhance
adherence to
the 10-day
regime
Blister pack
needs no box
Soap
Produce locally
Leaflet Packaging
Remove
constraint of
fitting in Coca-
Cola crate
Produce locally
Produce re-fill
option
4Oct 2013 | Incorporating the learning into the scale-up
36. ORS
Reduce number
of sachets to 4
This may also
enhance
adherence to
the combined
therapy
Zinc
Produce locally
Design the
blister pack to
enhance
adherence to
the 10-day
regime
lister pack needs
no box
Soap
Produce locally
Leaflet
Simplify –
single fold.
Same leaflet
for all formats
Packaging
Remove
constraint of
fitting in Coca-
Cola crate
Produce locally
Produce re-fill
option
4Oct 2013 | Incorporating the learning into the scale-up
38. ORS
Reduce number
of sachets to 4
This may also
enhance
adherence to
the combined
therapy
Zinc
Produce locally
Design the
blister pack to
enhance
adherence to
the 10-day
regime
Blister pack
needs no box
Soap
Produce locally
Leaflet
Simplify –
single fold.
Same leaflet
for all formats
Packaging
Remove
constraint of
fitting in Coca-
Cola crate. Only
4% of retailers
used this option
Produce locally
Produce re-fill
option
4Oct 2013 | Incorporating the learning into the scale-up
44. The data contained in this presentation are unpublished and based
on preliminary analysis of data from the ColaLife Operational Trial
in Zambia (COTZ). Final calculations may vary and will be published
in peer reviewed literature in due course.
In the interim, the following citation may be used: Ramchandani, R.
et al. (2014). ColaLife Operational Trial Zambia (COTZ) Evaluation.
Johns Hopkins Bloomberg School of Public Health, Baltimore.
Related correspondence should be sent to Rohit Ramchandani
(roramcha@jhsph.edu) and copied to Simon Berry
(simon@colalife.org).
A note on the data contained within this presentation
Notas do Editor
ColaLife & product innovation – a presentation for the Diarrhoea & Pneumonia Coordination Committee, Uganda.
I have no commercial interest in the commercial product I will show you.
But are strategy for impact is that others will find it of commercial interest – more of that later.
The timeline
This was our original award-winning idea. But this is what happened in practice.
It was the space in the market not the space in the crates that was important.
This was our original award-winning idea. But this is what happened in practice.
It was the space in the market not the space in the crates that was important.
The Kit Yamoyo has captured people’s imagination and won many global health, design and innovation awards.
In Sep-13 it was featured at the UN General Assembly as a breakthrough innovation in Child Health.
In Mar-14 it was show-cased by PATH and PSI in their Best Buys for Global Health initiative.
We are now moving to a national scale-up where will hand over the product to the private sector.
To do that we need to apply the learning from the trial and bring the cost of production down.
We need to look at all components of the kit including the packaging.
All components of the Kit Yamoyo were reviewed based on the findings of the trial.
First we will reduce the number of ORS sachets to 4 (from 8) this will halve the cost of the ORS component while at the same time enhance adherence to the combined ORS and Zinc regime.
75% of care-givers used 4 ORS sachets or less. Reducing the number of sachets from 8 to 4 will improve adherence to the combined therapy and halve the cost of the ORS component.
Our pharmaceutical partner in the trial as been inspired to produce Zinc locally. The first samples were put down for stability testing in Nov-13.
This provides the opportunity to design are own Zinc packaging. We’ve improved adherence to the correct measuring of ORS through design, can we do the same for Zinc adherence and improve adherence to the 10-day regime.
The locally produced Zinc will be cheaper and there will be no need for it to be in its own box which will also reduce costs.
We have persuaded the only soap manufacturer in Zambia to produce a small 25g bar of soap.
This will replace the soap imported from India.
They will sell the soap themselves as a stand-alone product.
We will simplify the leaflet and reduce costs by making a single fold format.
We will simplify the leaflet and reduce costs by making a single fold format.
Because the kit no longer needs to fit in the Coca-Cola crates we can move to locally produced option – a screw-top jar which is 40% cheaper than the current packaging.
In the scale-up we will be using two new packaging formats:
• a screw-top
• a flexible pack
The screw top will have all the functionality of the original packaging.
The flexible pack can measure the water.
So, in Zambia, we are no longer using the packaging that won the DuPont Diamond Award just last year. We’ve moved on and are using these formats instead.
This Screw-top incorporates all the features of the original AidPod. In fact it’s a better measuring device, mixing device, storage device and cup AND it’s cheaper and it can be made in Zambia.
And this humble, pop-open, Flexi-pack – developed for us by Amcor – is even cheaper. And it can also measure the water and is free standing when you pour water in it.